Concepts (198)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Acinetobacter Infections | 1 | 2015 | 69 | 0.520 |
Why?
|
| Carbapenems | 1 | 2015 | 118 | 0.500 |
Why?
|
| Acinetobacter baumannii | 1 | 2015 | 107 | 0.490 |
Why?
|
| Midazolam | 5 | 2001 | 270 | 0.440 |
Why?
|
| Atracurium | 2 | 2008 | 52 | 0.440 |
Why?
|
| Prilocaine | 1 | 2010 | 19 | 0.380 |
Why?
|
| Tetracaine | 1 | 2010 | 35 | 0.370 |
Why?
|
| Hysterectomy, Vaginal | 2 | 2008 | 37 | 0.350 |
Why?
|
| Phlebotomy | 1 | 2010 | 141 | 0.340 |
Why?
|
| Anesthetics, Local | 2 | 2010 | 985 | 0.340 |
Why?
|
| Hemodynamics | 9 | 2001 | 4199 | 0.330 |
Why?
|
| Dipyrone | 1 | 2008 | 9 | 0.320 |
Why?
|
| Anesthesia, Local | 1 | 2010 | 275 | 0.310 |
Why?
|
| Hypertonic Solutions | 1 | 2007 | 93 | 0.300 |
Why?
|
| Prednisolone | 1 | 2008 | 334 | 0.290 |
Why?
|
| Lidocaine | 1 | 2010 | 544 | 0.290 |
Why?
|
| Oxidants | 1 | 2007 | 164 | 0.290 |
Why?
|
| Leukocyte Elastase | 1 | 2007 | 113 | 0.290 |
Why?
|
| Isoxazoles | 1 | 2008 | 216 | 0.280 |
Why?
|
| Superoxides | 1 | 2007 | 387 | 0.270 |
Why?
|
| Disease Outbreaks | 1 | 2015 | 1772 | 0.270 |
Why?
|
| Pain, Postoperative | 3 | 2008 | 1643 | 0.270 |
Why?
|
| Neuromuscular Junction | 1 | 2008 | 398 | 0.270 |
Why?
|
| Anesthesia, Intravenous | 2 | 1996 | 130 | 0.240 |
Why?
|
| Enoximone | 2 | 1993 | 9 | 0.240 |
Why?
|
| Bupivacaine | 2 | 2000 | 411 | 0.230 |
Why?
|
| Coronary Artery Bypass | 3 | 2007 | 2289 | 0.230 |
Why?
|
| Halothane | 2 | 1993 | 206 | 0.230 |
Why?
|
| Isoflurane | 3 | 2002 | 380 | 0.220 |
Why?
|
| Capnography | 1 | 2003 | 89 | 0.220 |
Why?
|
| Anesthesia, Inhalation | 2 | 1993 | 223 | 0.210 |
Why?
|
| Intensive Care Units | 1 | 2015 | 3679 | 0.210 |
Why?
|
| Sufentanil | 1 | 2001 | 40 | 0.200 |
Why?
|
| Anesthetics, Combined | 1 | 2001 | 40 | 0.200 |
Why?
|
| Propofol | 2 | 2001 | 629 | 0.200 |
Why?
|
| Sotalol | 1 | 1999 | 49 | 0.180 |
Why?
|
| Cardiac Output | 4 | 2007 | 854 | 0.180 |
Why?
|
| Emergency Treatment | 1 | 2003 | 517 | 0.170 |
Why?
|
| Episiotomy | 1 | 1999 | 24 | 0.170 |
Why?
|
| Glucocorticoids | 1 | 2008 | 2107 | 0.160 |
Why?
|
| Thoracotomy | 1 | 2000 | 363 | 0.160 |
Why?
|
| Anti-Bacterial Agents | 1 | 2015 | 7181 | 0.150 |
Why?
|
| Analgesia, Patient-Controlled | 3 | 2008 | 109 | 0.150 |
Why?
|
| Tachycardia | 1 | 1999 | 619 | 0.150 |
Why?
|
| Conscious Sedation | 1 | 2001 | 528 | 0.140 |
Why?
|
| Piperidines | 2 | 2002 | 1602 | 0.140 |
Why?
|
| Puerperal Disorders | 1 | 1999 | 275 | 0.140 |
Why?
|
| Short Bowel Syndrome | 1 | 1999 | 345 | 0.140 |
Why?
|
| Preanesthetic Medication | 3 | 2002 | 49 | 0.140 |
Why?
|
| Anesthesia Recovery Period | 3 | 2008 | 157 | 0.130 |
Why?
|
| Analgesia | 1 | 2000 | 461 | 0.130 |
Why?
|
| beta-Lactam Resistance | 1 | 2015 | 79 | 0.130 |
Why?
|
| Pirinitramide | 2 | 2008 | 3 | 0.130 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 1999 | 789 | 0.130 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2001 | 1121 | 0.130 |
Why?
|
| Escherichia coli Infections | 1 | 1999 | 532 | 0.130 |
Why?
|
| Neutrophils | 1 | 2007 | 3719 | 0.120 |
Why?
|
| Streptococcal Infections | 1 | 1999 | 638 | 0.120 |
Why?
|
| Plethysmography, Impedance | 2 | 1990 | 43 | 0.110 |
Why?
|
| Cardiography, Impedance | 2 | 1990 | 41 | 0.110 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2008 | 2425 | 0.110 |
Why?
|
| Hypnotics and Sedatives | 1 | 2001 | 1162 | 0.110 |
Why?
|
| Thoracic Diseases | 1 | 1993 | 97 | 0.110 |
Why?
|
| Pain Measurement | 3 | 2010 | 3420 | 0.110 |
Why?
|
| Coronary Vessel Anomalies | 1 | 1996 | 314 | 0.110 |
Why?
|
| Lithotripsy | 2 | 1993 | 143 | 0.100 |
Why?
|
| Analgesics, Opioid | 3 | 2008 | 3674 | 0.100 |
Why?
|
| Bacteremia | 1 | 1999 | 962 | 0.100 |
Why?
|
| Hernia, Inguinal | 1 | 1994 | 210 | 0.100 |
Why?
|
| Double-Blind Method | 4 | 2010 | 12026 | 0.100 |
Why?
|
| Thoracic Neoplasms | 1 | 1993 | 268 | 0.100 |
Why?
|
| Anesthesia, Spinal | 1 | 1994 | 269 | 0.090 |
Why?
|
| Vasoconstriction | 1 | 1993 | 597 | 0.090 |
Why?
|
| Critical Care | 2 | 2001 | 2647 | 0.090 |
Why?
|
| Respiration Disorders | 1 | 1994 | 371 | 0.090 |
Why?
|
| Epinephrine | 1 | 1994 | 792 | 0.090 |
Why?
|
| Intraoperative Complications | 2 | 1995 | 1198 | 0.090 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 1997 | 980 | 0.090 |
Why?
|
| Microcomputers | 1 | 1989 | 147 | 0.090 |
Why?
|
| Surgical Wound Infection | 1 | 1999 | 1540 | 0.080 |
Why?
|
| Vascular Resistance | 2 | 2007 | 936 | 0.080 |
Why?
|
| Online Systems | 1 | 1989 | 184 | 0.080 |
Why?
|
| Otorhinolaryngologic Diseases | 1 | 1989 | 90 | 0.080 |
Why?
|
| Infection Control | 1 | 2015 | 966 | 0.080 |
Why?
|
| Thrombolytic Therapy | 1 | 1997 | 2161 | 0.080 |
Why?
|
| Administration, Cutaneous | 1 | 2010 | 711 | 0.080 |
Why?
|
| Computer Graphics | 1 | 1989 | 361 | 0.080 |
Why?
|
| Neuromuscular Nondepolarizing Agents | 1 | 2008 | 147 | 0.070 |
Why?
|
| Endpoint Determination | 1 | 2010 | 601 | 0.070 |
Why?
|
| Behavior | 1 | 2010 | 561 | 0.070 |
Why?
|
| Neuromuscular Blockade | 1 | 2008 | 146 | 0.070 |
Why?
|
| Injections, Intravenous | 2 | 2008 | 1420 | 0.070 |
Why?
|
| Anesthesia | 2 | 2007 | 1561 | 0.070 |
Why?
|
| Osmolar Concentration | 1 | 2007 | 683 | 0.070 |
Why?
|
| Anesthetics, Intravenous | 2 | 2002 | 417 | 0.070 |
Why?
|
| Water-Electrolyte Balance | 1 | 2007 | 346 | 0.070 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2008 | 371 | 0.070 |
Why?
|
| Hematocrit | 1 | 2007 | 636 | 0.070 |
Why?
|
| Middle Aged | 16 | 2015 | 213383 | 0.070 |
Why?
|
| Anesthesia, General | 2 | 1989 | 1171 | 0.060 |
Why?
|
| Aged | 12 | 2015 | 163280 | 0.060 |
Why?
|
| Pulmonary Embolism | 1 | 1997 | 2376 | 0.060 |
Why?
|
| Child Behavior | 1 | 1990 | 839 | 0.060 |
Why?
|
| Female | 19 | 2015 | 380194 | 0.060 |
Why?
|
| Prospective Studies | 5 | 2010 | 53288 | 0.060 |
Why?
|
| Arousal | 1 | 1989 | 1165 | 0.060 |
Why?
|
| Leukocyte Count | 1 | 2007 | 1588 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2008 | 10943 | 0.050 |
Why?
|
| Monitoring, Physiologic | 2 | 1990 | 1738 | 0.050 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 1989 | 1534 | 0.050 |
Why?
|
| Humans | 28 | 2015 | 744343 | 0.050 |
Why?
|
| Sodium | 1 | 2007 | 1623 | 0.050 |
Why?
|
| Male | 15 | 2015 | 350118 | 0.050 |
Why?
|
| Adult | 14 | 2008 | 214055 | 0.050 |
Why?
|
| Drug Administration Schedule | 1 | 2008 | 4933 | 0.040 |
Why?
|
| Biological Availability | 1 | 1999 | 397 | 0.040 |
Why?
|
| Pleura | 1 | 2000 | 235 | 0.040 |
Why?
|
| Respiration, Artificial | 2 | 2001 | 2569 | 0.040 |
Why?
|
| Hemofiltration | 1 | 1999 | 57 | 0.040 |
Why?
|
| Aged, 80 and over | 4 | 2015 | 57776 | 0.040 |
Why?
|
| Multiple Trauma | 1 | 2001 | 367 | 0.040 |
Why?
|
| Adolescent | 5 | 2010 | 85781 | 0.040 |
Why?
|
| Statistics, Nonparametric | 1 | 2003 | 2886 | 0.040 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2008 | 2282 | 0.040 |
Why?
|
| Anesthetics, Inhalation | 1 | 2002 | 570 | 0.040 |
Why?
|
| Injections | 1 | 2000 | 840 | 0.040 |
Why?
|
| Postoperative Complications | 3 | 2000 | 15295 | 0.040 |
Why?
|
| Oxygen | 2 | 2007 | 4189 | 0.040 |
Why?
|
| Electroencephalography | 2 | 2002 | 6150 | 0.040 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 1997 | 336 | 0.040 |
Why?
|
| Streptococcus pyogenes | 1 | 1999 | 289 | 0.040 |
Why?
|
| Heart Rate | 2 | 2001 | 4091 | 0.030 |
Why?
|
| Anxiety | 1 | 1990 | 4297 | 0.030 |
Why?
|
| Mouth Neoplasms | 1 | 2001 | 601 | 0.030 |
Why?
|
| Dobutamine | 1 | 1996 | 123 | 0.030 |
Why?
|
| Equipment Design | 1 | 2003 | 3582 | 0.030 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 1996 | 177 | 0.030 |
Why?
|
| Pain | 1 | 2010 | 4986 | 0.030 |
Why?
|
| Lung | 1 | 1993 | 9856 | 0.030 |
Why?
|
| Genital Diseases, Female | 1 | 1995 | 197 | 0.030 |
Why?
|
| Alfentanil | 1 | 1993 | 27 | 0.030 |
Why?
|
| Time Factors | 3 | 2008 | 40075 | 0.030 |
Why?
|
| Ventilation-Perfusion Ratio | 1 | 1993 | 116 | 0.030 |
Why?
|
| Child, Preschool | 3 | 2010 | 41006 | 0.030 |
Why?
|
| Norepinephrine | 1 | 1996 | 909 | 0.030 |
Why?
|
| Fentanyl | 1 | 1996 | 410 | 0.030 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 1993 | 264 | 0.030 |
Why?
|
| Chemotherapy, Cancer, Regional Perfusion | 1 | 1993 | 85 | 0.030 |
Why?
|
| Cardiotonic Agents | 1 | 1996 | 535 | 0.030 |
Why?
|
| Stroke Volume | 2 | 1996 | 5007 | 0.020 |
Why?
|
| Fever | 1 | 1999 | 1616 | 0.020 |
Why?
|
| Cardiopulmonary Bypass | 1 | 1996 | 1066 | 0.020 |
Why?
|
| Thermodilution | 1 | 1990 | 52 | 0.020 |
Why?
|
| Arm | 1 | 1993 | 589 | 0.020 |
Why?
|
| Abdomen | 1 | 1995 | 1118 | 0.020 |
Why?
|
| Syndrome | 1 | 1996 | 3251 | 0.020 |
Why?
|
| Hyperthermia, Induced | 1 | 1993 | 403 | 0.020 |
Why?
|
| Child | 4 | 2010 | 77709 | 0.020 |
Why?
|
| Wounds and Injuries | 1 | 2001 | 2400 | 0.020 |
Why?
|
| Dopamine | 1 | 1996 | 1591 | 0.020 |
Why?
|
| Aorta | 1 | 1996 | 2061 | 0.020 |
Why?
|
| Fibrinolytic Agents | 1 | 1997 | 2158 | 0.020 |
Why?
|
| Leg | 1 | 1993 | 1116 | 0.020 |
Why?
|
| Blood Pressure | 3 | 1993 | 8554 | 0.020 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1993 | 1504 | 0.020 |
Why?
|
| Problem Solving | 1 | 1989 | 440 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 1993 | 1869 | 0.020 |
Why?
|
| Escherichia coli | 1 | 1999 | 4217 | 0.020 |
Why?
|
| Sleep Stages | 1 | 1990 | 686 | 0.020 |
Why?
|
| Infant | 3 | 1996 | 35136 | 0.020 |
Why?
|
| Positive-Pressure Respiration | 1 | 1990 | 633 | 0.020 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 1996 | 2073 | 0.020 |
Why?
|
| Coronary Vessels | 1 | 1996 | 3107 | 0.010 |
Why?
|
| Laparoscopy | 1 | 1995 | 2151 | 0.010 |
Why?
|
| Soft Tissue Neoplasms | 1 | 1993 | 1363 | 0.010 |
Why?
|
| Administration, Oral | 1 | 1991 | 3913 | 0.010 |
Why?
|
| Diazepam | 1 | 2002 | 205 | 0.010 |
Why?
|
| Surgical Procedures, Operative | 1 | 1993 | 1876 | 0.010 |
Why?
|
| Sarcoma | 1 | 1993 | 1897 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 1993 | 4456 | 0.010 |
Why?
|
| Heart Ventricles | 1 | 1989 | 3821 | 0.010 |
Why?
|
| Pregnancy | 1 | 1999 | 29144 | 0.010 |
Why?
|
| Monitoring, Intraoperative | 1 | 2002 | 957 | 0.010 |
Why?
|
| Software | 1 | 1989 | 4443 | 0.010 |
Why?
|
| Melanoma | 1 | 1993 | 5510 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 1996 | 39050 | 0.010 |
Why?
|
| Partial Pressure | 1 | 1993 | 254 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 1994 | 25625 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 1993 | 11524 | 0.010 |
Why?
|
| Melphalan | 1 | 1993 | 431 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 1993 | 1525 | 0.010 |
Why?
|
| Intraoperative Period | 1 | 1990 | 520 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1990 | 1681 | 0.000 |
Why?
|
| Cisplatin | 1 | 1993 | 1662 | 0.000 |
Why?
|
| Risk Factors | 1 | 1993 | 72290 | 0.000 |
Why?
|
| Reproducibility of Results | 1 | 1990 | 19905 | 0.000 |
Why?
|
| Brain Neoplasms | 1 | 1990 | 8863 | 0.000 |
Why?
|
| Animals | 1 | 1995 | 168757 | 0.000 |
Why?
|
Concepts
(198)
Derived automatically from this person's publications.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_